BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    ACCU-CHEK SPIRIT COMBO

    MDR report key: 3122879 · Received May 21, 2013

    Report

    Report Number
    2183996-2013-00902
    Event Type
    Malfunction
    Date Received
    May 21, 2013
    Date of Event
    May 16, 2013
    Report Date
    July 8, 2013
    Manufacturer
    ROCHE DIABETES CARE AG
    Product Code
    LZG
    PMA / PMN Number
    NA
    Removal / Correction Number
    NA
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    UK
    Reporter Occupation
    MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

    Narratives

    Additional Manufacturer Narrative · 1

    THE INCIDENT OCCURRED OUTSIDE THE UNITED STATES. INFORMATION CONTAINED WITHIN THIS REPORT IS ALL THAT IS AVAILABLE AT THIS TIME. IF FURTHER INFORMATION IS OBTAINED, IT WILL BE PROVIDED IN THE SUPPLEMENTAL REPORT.

    Additional Manufacturer Narrative · 1

    THE SOFT COMPONENTS OF THE CHECK/MENU BUTTON ARE LACERATED. THE MENU AND CHECK BUTTON ARE DIFFICULT TO PRESS THAT IS CAUSED BY THE ENTERED CONTAMINATION HOWEVER THE FUNCTIONALITY IS NOT AFFECTED. THE DAMAGES DID NOT INFLUENCE THE FUNCTIONALITY OF THE INSULIN PUMP. THE PROBLEM MENTIONED BY THE CUSTOMER IS RELATED TO CARELESS HANDLING OF THE PRODUCT.

    Description of Event or Problem · 1

    ON (B)(6) 2013, IT WAS REPORTED THAT THE MENU AND CHECK BUTTONS ON THE PATIENT'S INFUSION DEVICE WERE STICKING, DIFFICULT TO PRESS, AND ONLY RESPONDING INTERMITTENTLY. THE PATIENT ALSO STATED THAT THE RUBBER CASING AROUND THE BUTTONS WAS DAMAGED. NO PHYSIOLOGICAL EFFECTS WERE REPORTED. THE PATIENT DID NOT REQUIRE MEDICAL ASSISTANCE FROM A HEALTHCARE PROFESSIONAL OR SECOND PARTY TO ADDRESS THE ISSUE. THE INFUSION DEVICE WAS REQUESTED TO BE RETURNED FOR PRODUCT EVALUATION.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    224349 ACCU-CHEK SPIRIT COMBO INSULIN INFUSION DEVICE LZG ROCHE DIABETES CARE AG 00700006863 NA

    Patients

    Seq Age Sex Outcome Treatment
    1 025 YR